Takuya Genda

Shizuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Non-imaging indices for attenuation imaging-defined steatotic liver disease: fatty liver index and hepatic steatosis index.

Non-imaging indices for attenuation imaging-defined steatotic liver disease: fatty liver index and hepatic steatosis index.

Journal: Scandinavian journal of gastroenterology

Published: July 30, 2026

Differential Hepatitis B Surface Antigen Glycan Isomer Kinetics Between Tenofovir Alafenamide and Entecavir: Hepatocellular Carcinoma Risk Stratification in Hepatitis B e Antigen-Positive Patients.

Differential Hepatitis B Surface Antigen Glycan Isomer Kinetics Between Tenofovir Alafenamide and Entecavir: Hepatocellular Carcinoma Risk Stratification in Hepatitis B e Antigen-Positive Patients.

Journal: Journal of viral hepatitis

Published: April 23, 2026

Low Alpha-Fetoprotein in Non-Viral Early-Stage Hepatocellular Carcinoma: Complementary Des-Gamma-Carboxyprothrombin.

Low Alpha-Fetoprotein in Non-Viral Early-Stage Hepatocellular Carcinoma: Complementary Des-Gamma-Carboxyprothrombin.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: March 02, 2026

Ten-Year Trends in First- and Second-Line Helicobacter pylori Eradication Rates at a Regional Hospital in Japan.

Ten-Year Trends in First- and Second-Line Helicobacter pylori Eradication Rates at a Regional Hospital in Japan.

Journal: Juntendo medical journal

Published: January 15, 2026

Elevated Serum Interleukin 6 Is Associated With High Risk of First Non-bleeding Decompensation in Patients With Compensated Cirrhosis.

Elevated Serum Interleukin 6 Is Associated With High Risk of First Non-bleeding Decompensation in Patients With Compensated Cirrhosis.

Journal: In vivo (Athens, Greece)

Published: December 16, 2025

Durable response to chemotherapy enabling conversion surgery in stage IVB gallbladder cancer: a case successfully treated with durvalumab combined with gemcitabine plus cisplatin.

Durable response to chemotherapy enabling conversion surgery in stage IVB gallbladder cancer: a case successfully treated with durvalumab combined with gemcitabine plus cisplatin.

Journal: Clinical journal of gastroenterology

Published: September 13, 2025

Association of Exercise Tolerance with Survival in Patients with Hepatocellular Carcinoma Receiving Locoregional Therapy.

Association of Exercise Tolerance with Survival in Patients with Hepatocellular Carcinoma Receiving Locoregional Therapy.

Journal: Progress in rehabilitation medicine

Published: July 16, 2025

Fibrosis in Asymptomatic Steatotic Liver Disease With Normal Alanine Aminotransferase: Analysis of 2448 Health Check-Up Cohort by Ultrasound Attenuation Imaging and Shear Wave Elastography.

Fibrosis in Asymptomatic Steatotic Liver Disease With Normal Alanine Aminotransferase: Analysis of 2448 Health Check-Up Cohort by Ultrasound Attenuation Imaging and Shear Wave Elastography.

Journal: Journal of gastroenterology and hepatology

Published: July 15, 2025

Liver Volumetry Enhances Prediction of Acute Pancreatitis in Acute Liver Failure: A Nationwide Registry Study.

Liver Volumetry Enhances Prediction of Acute Pancreatitis in Acute Liver Failure: A Nationwide Registry Study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 29, 2025

Clinical Evaluation of Initial Experiences With the Qualitative Dual Detection of Core Antigen and Antibodies Immunoassay for Hepatitis C Virus Screening Test.

Clinical Evaluation of Initial Experiences With the Qualitative Dual Detection of Core Antigen and Antibodies Immunoassay for Hepatitis C Virus Screening Test.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 24, 2025

Nivolumab plus Ipilimumab versus Lenvatinib or Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: CheckMate 9DW Japanese Subgroup Analysis.

Nivolumab plus Ipilimumab versus Lenvatinib or Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: CheckMate 9DW Japanese Subgroup Analysis.

Journal: Liver cancer

Published: May 19, 2025

Nationwide survey of patients with acute liver failure and late-onset hepatic failure in Japan seen between 2016 and 2021.

Nationwide survey of patients with acute liver failure and late-onset hepatic failure in Japan seen between 2016 and 2021.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: November 01, 2024

Showing 1-12 of 81

Last Updated: 09/26/2026